Back to News
Retail news

Studies Show Pfizer's New Anti-Smoking Drug More Effective

In one recent study, Chantix, a new anti-smoking remedy to be sold by Pfizer, showed better results among 44 percent of smokers tested as compared with rival bupropion, marketed under the brands Zyban and Wllbutrin.

The RetailWire Daily

A daily briefing with the retail news, expert perspective, and business context to bring into your next meeting.

Want to know more? Learn more

Discussion Thread0